Immunesensor Therapeutics

Immunesensor Therapeutics company information, Employees & Contact Information

ImmuneSensor is developing novel medicines that target the cGAS (cyclic GMP-AMP synthase) - STING (stimulator of interferon genes) pathway of the innate immune system to treat cancer and autoimmune diseases. The Company has licensed technologies from the laboratory of Dr. Zhijian "James" Chen, Professor of Molecular Biology at the University of Texas Southwestern Medical Center and Investigator of Howard Hughes Medical Institute. Dr. Chen discovered cGAS and its product cGAMP, which activates STING to stimulate immune responses. These discoveries form the technological foundation of ImmuneSensor. ImmuneSensor's lead program, IMSA101 is a STING activator currently in clinical development for cancer therapy. There are also multiple new drug candidates emerging from the company research, including an exciting cGAS inhibitor program designed to suppress overactivated autoimmunity.

Company Details

Employees
11
Address
2110 Research Row, Dallas,texas 75235,united States
Phone
+1 469 757 5110
Email
in****@****sor.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Dallas, Texas
Looking for a particular Immunesensor Therapeutics employee's phone or email?

Immunesensor Therapeutics Questions

Top Immunesensor Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant